COMP vs RARE · rev $5.63B vs rev $560.2M
Compass Inc (COMP) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
COMP currently screens at market cap $3.35B. RARE currently screens at market cap $2.79B.
Not investment advice. Open the COMP and RARE stock pages for the full models.
Not investment advice.